Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Am J Gastroenterol. 2010 Feb 9;105(6):1412–1420. doi: 10.1038/ajg.2010.10

Table 1.

Summary of Cohort at Time of CD Diagnosis

Variable Total
(n=241)
Age at CD diagnosis* 47 (18, 84)
Gender
.   Male 65 (27%)
.   Female 176 (73%)
Decade of CD diagnosis
.   1970s 2 (1%)
.   1980s 6 (2%)
.   1990s 47 (20%)
.   2000s 186 (77%)
Clinical presentation
.   Classical 157 (65%)
.   Atypical 76 (32%)
.   Silent 8 (3%)
Diarrhea 157 (65%)
Weight loss 109 (45%)
Severe CD 87 (36%)
Autoimmune disease 49 (21%)
Positive tTGA at CD diagnosis 93/110 (85%)
tTGA titer at CD diagnosis* 83 (20, 250)
Positive EMA at CD diagnosis 89/116 (77%)
EMA titer at CD diagnosis* 160 (5, 2560)
Positive tTGA or EMA at CD diagnosis 126/160 (79%)
Intraepithelial lymphocytes at CD diagnosis* 75 (20, 200)
Villous atrophy at CD diagnosis
.   Partial 123 (51%)
.   Total 118 (49%)
Villous to crypt ratio at CD diagnosis* 0.2 (0.0,2.0)
*

Median (Min, Max)

CD, celiac disease; tTGA, tissue transglutaminase antibody; EMA, endomysial antibody